Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joni L Rutter

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Oncogene|July 11, 2003
CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARFJoni L Rutter, Alisa M Goldstein, Michael R Dávila, et al.
Neuroepigenetics|February 28, 2015
Neuroepigenomics: Resources, Obstacles, and OpportunitiesJohn S Satterlee, Andrea Beckel-Mitchener, Roger Little, et al.
The New England Journal of Medicine|August 15, 2019
The "All of Us" Research Program, Joshua C Denny, Joni L Rutter, et al.
BMC Cancer|April 29, 2004
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genesAlice J Sigurdson, Michael Hauptmann, Nilanjan Chatterjee, et al.
Journal of the National Cancer Institute|August 21, 2003
Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer riskMichael Hauptmann, Alice J Sigurdson, Nilanjan Chatterjee, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2014
Community resources and technologies developed through the NIH Roadmap Epigenomics ProgramJohn S Satterlee, Andrea Beckel-Mitchener, Kim McAllister, et al.
Journal of the National Cancer Institute|July 17, 2003
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control studyJoni L Rutter, Sholom Wacholder, Angela Chetrit, et al.
Mutation Research|October 19, 2006
Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyomaSusan E Ingraham, Roy A Lynch, Urvashi Surti, et al.
Journal of Clinical and Translational Science|July 17, 2023
A framework for assessing clinical trial site readinessJohn B Buse, Christopher P Austin, S Claiborne Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasisKristin K Nelson, Aparna C Ranganathan, Jelriza Mansouri, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Oncogene|July 11, 2003
CDKN2A point mutations D153spl(c.457G>T) and IVS2+1G>T result in aberrant splice products affecting both p16INK4a and p14ARFJoni L Rutter, Alisa M Goldstein, Michael R Dávila, et al.
Neuroepigenetics|February 28, 2015
Neuroepigenomics: Resources, Obstacles, and OpportunitiesJohn S Satterlee, Andrea Beckel-Mitchener, Roger Little, et al.
The New England Journal of Medicine|August 15, 2019
The "All of Us" Research Program, Joshua C Denny, Joni L Rutter, et al.
BMC Cancer|April 29, 2004
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genesAlice J Sigurdson, Michael Hauptmann, Nilanjan Chatterjee, et al.
Journal of the National Cancer Institute|August 21, 2003
Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer riskMichael Hauptmann, Alice J Sigurdson, Nilanjan Chatterjee, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 26, 2014
Community resources and technologies developed through the NIH Roadmap Epigenomics ProgramJohn S Satterlee, Andrea Beckel-Mitchener, Kim McAllister, et al.
Journal of the National Cancer Institute|July 17, 2003
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control studyJoni L Rutter, Sholom Wacholder, Angela Chetrit, et al.
Mutation Research|October 19, 2006
Identification and characterization of novel human transcripts embedded within HMGA2 in t(12;14)(q15;q24.1) uterine leiomyomaSusan E Ingraham, Roy A Lynch, Urvashi Surti, et al.
Journal of Clinical and Translational Science|July 17, 2023
A framework for assessing clinical trial site readinessJohn B Buse, Christopher P Austin, S Claiborne Johnston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Elevated sod2 activity augments matrix metalloproteinase expression: evidence for the involvement of endogenous hydrogen peroxide in regulating metastasisKristin K Nelson, Aparna C Ranganathan, Jelriza Mansouri, et al.
Pageof 4